Appearances
- ATVB Journal Session: From Cells to the Clinic: Progress in the Development of Novel Therapeutics for ATVB Diseases
- Clinical Lipidology Update
- Groundbreaking Studies in the Practice of Cardiovascular Medicine
- Cardiovascular Nursing Clinical Symposium
- Device Therapy and Arrhythmia Management in LVAD and Heart Transplant Recipients
- Flipped Classroom: Reviewing (and arguing about) Interesting ECGs
- Working Towards an Expert Consensus for the Management of Acute Type A Dissections: In Collaboration with the Society of Thoracic Surgeons
- Air Pollution and Hypertension
- Aortic Stent Grafts: The Good, The Bad, The Ugly
- Atrial Fibrillation, Stroke, and Intracerebral Hemorrhage: Complex Cases
- Big Data, Small Data: David & Goliath
- Discussion - Big Questions in Gender and Ethnicity in Pulmonary Arterial Hypertension and Peripheral Vascular Disease
- Big Questions in Gender and Ethnicity in Pulmonary Arterial Hypertension and Peripheral Vascular Disease
- Cardiotoxicity of Cancer Therapeutics: Novel Mechanisms
- Controversies in Exercise Training
- Controversies in the Management of Cardiogenic Shock: A Mini-Debate Series
- Diets from Vegan to Ketogenic: What’s the Best for CV Health and for Which Patient?
- Disparities in Heart Failure Care and Treatment: Are We Reaching the Most Vulnerable Patients?
- Epigenetic Mechanisms of Hypertension
- Fact or Fiction: Clinical Controversies in Heart Failure
- Interventional Treatments for Hypertension
- Key Pearls for Success from Diverse Leaders in Cardiovascular Surgery and Anesthesia
- Late Breaking Clinical Trial: Novel Approaches to CV Prevention
- Moving beyond QI Registry Data for Real Cardiovascular Care Improvement
- Navigating Early Career Waters: Mentors, Funding, and Life Balance?
- Neurocardiology: The Brain-Heart Connection
- Neurocognitive Challenges of Adolescents and Emerging Adults with Congenital Heart Disease
- Non-ST-elevation Acute Coronary Syndromes: 2018 and Beyond
- Nurses Improving Outcomes: Overcoming Barriers
- Obesity and HFpEF – Fat, Fitness and Frontiers for Novel Therapeutic Strategies
- Shocking Controversies from the Edge! Saving the Sickest Against All Odds
- Starting and Maintaining a Research Career in Clinical or Population Science
- Structural Heart Disease, 3D imaging, and Artificial Intelligence
- Target BP in Action: A Path to better Blood Pressure Control
- The Swollen Limb: Epidemiology, Diagnosis and Treatment Options
- Thrombosis and Thrombophilia: An Under-Recognized Cardiovascular Concern in Women's Health
- Variability of Blood Pressure and Cardiovascular Disease Risk
- Vasculo-Oncology Crash-Course: How to Handle Vascular Complications in Cancer Patients
- What Every Cardiologist Needs to Know About Comprehensive CV Risk Reduction in Diabetes
- AHA/SCAI Hot Topics in Structural Heart Disease: What's Happening Now? What's Next?
- Communication: Pearls and Perils
- Controversies in Pediatric Cardiology and Cardiac Surgery
- Ethical Dilemmas in Pediatric Cardiac Care
- Innovative Therapies for Heart Recovery: Mechanical Ventricular Unloading
- Interactive Cases on Changing the Paradigm of CV Prevention: Using Lipid Targets, the New Hypertension Guidelines, Novel Glucose-Lowering Therapies, and Coronary Calcium
- Novel Therapies for PAH: The next generation of Clinical Trials
- Resistant Hypertension
- What every Cardiologist needs to know about Vascular Disease and its Management
- Developing Competency-Based Medical Nutrition Education and Training to Advance ASCVD Prevention by Physicians--Leveraging 21st Century Curricula Reforms, Population Health Goals, and NHLBI Roles/Partnerships
- Prevention of Heart Failure- Moving From Theory to Practice
- Reducing Cardiometabolic Risk by Improving Sleep
- Women in Cardiovascular Disease: BYOB (Breakfast) With Women Pioneers Networking Event
- Management of Hypertension in Special Populations
- Can We Develop Therapies to Mimic the Benefits of Exercise?
- Clinical Trials and Challenging Interventional Cases: The 2018 Perspective
- Emerging Concepts about RNA in the Cardiovascular System
- Management of Acute Cardiovascular Disease in Older Adults: The influence of multi-morbidity and frailty in the Coronary Care Unit
- Molecular and Cellular Regulation of Cardiac Inflammation
- Molecular and Metabolic Mechanisms Underlying Cardiomyopathy
- Nursing Science in Review
- Precision Medicine for Heart Failure
- The New Guidelines: Updating Your Practice Patterns, and Avoiding Potential Pitfalls
- Circulation: Cardiovascular Imaging - Editors Picks
- Clinical Management of Familial Hypercholesterolemia
- Meaningful Translational Research: Mouse to Human
- New Technology and Approaches to Arrhythmias: Ablation
- New Technology and Approaches to Arrhythmias: Devices
- State of the Art in Hypertrophic Cardiomyopathy: Beyond the Guidelines
- The 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: What Do You Need To Know?
- Vascular Modeling and Integrated Systems Biology Approaches
- Dilemmas in Antiplatelet Therapy after PCI
- Health Disparities Oral Abstracts
- Immune Cell Communication In Cardiovascular Disease
- Innovations in Secondary Prevention: Case Studies: In Collaboration with the Preventive Cardiovascular Nurses Association
- Delivering PAD Patients Optimal Care Today, Tomorrow and Beyond: Updates in your Therapeutic Armamentarium
- Mentoring and Leadership Perspectives on Gender and Early Career Success
- The Present and Future of Exercise and Interventions for PAD
- The Present and Future of Imaging and Treatment Approaches in PAD
- Recent Progress of Anticoagulation Therapy in Cardiovascular Disease: Joint Session with AHA & The Japanese Circulation Society
- Opening Remarks - Working Towards an Expert Consensus for the Management of Acute Type A Dissections: In Collaboration with the Society of Thoracic Surgeons
- Helen B. Taussig Memorial Lecture
- AF & HFrEF: The Great Debates
- Co-management of Patients with Diabetes and Heart Disease
- Effective Clinical Strategies to Reduce Obesity and Cardiometabolic Risk: Interactive Case Discussions
- Falling Out of Orbita: Lessons from a Provocative Randomized Clinical Trial
- Late Breaking Clinical Trial: Answers to Critical Questions in Cardiovascular Prevention
- Planning for the Urgency of Aging: What Do We Know About Optimal Care for the Very Elderly With Cardiovascular Disease?
- Population Screening for Atrial Fibrillation: Opportunities and Challenges
- Rx for Behavior Change: Engaging Patients to Meet Guidelines
- The Metabolic Face of Heart Failure
- U.S. Health Policy at the Crossroads: What Cardiovascular Clinicians Need to Know
- Unpacking the Cardiovascular Biology of Violence
- You Are What You Eat: The Intestinal Microbiome and Cardiometabolic Disease
- Zip Codes are More Important than Genetic Codes: Social and Environmental Determinants of CVD Risk
- Challenges in Anticoagulation and Stroke Prevention for AF
- Inherited Arrhythmia Challenges: An Updated Case-based Approach
- Prevention Beyond the Guidelines: What to Do Next
- Part I: Cerebral Protection Strategies: the Debate Continues
- Paul Dudley White International Lecture & Session
- Paul Dudley White International Lecture & Session
- PLACEHOLDER - Cholesterol Deep Dive Session
- PLACEHOLDER - Cholesterol Deep Dive Session
- Presidential Session
- Presidential Session
- Cardiovascular Disease and Breast Cancer
- EHR 3.0: The Future of Electronic Health Records
- #SoMe #AHA - Leveraging Social Media in Cardiovascular Medicine
- Debates in Cardiovascular Care: Making Arguments Great Again (#MAGA)
- Next Generation Phenotyping for Cardiovascular and Stroke Research
- State of the Heart For Women: Top Ten Advances in Gender-Specific Medicine
- Advanced Imaging of Coronary Artery Disease: Joint Session with AHA & the European Society of Cardiology (ESC)
- AF 2018: Pushing the Excellence Envelope: Joint Session with AHA & Heart Rhythm Society (HRS)
- Animal Models and Translational Insights
- Cardiac Ion Channels in Disease
- Cardiovascular Disease Prevention: Clinical Advice from Population Studies: Joint Session with AHA & the European Society of Cardiology (ESC)
- Dilated Cardiomyopathy (DCM) As A Dynamic Disease: Evolving Concepts and Management Strategies: Joint Session with AHA & the Brazilian Society of Cardiology
- Does This Patient Have an Indication for an ICD?
- Enhancing Reproducibility: Initiatives and Practical Tools
- Epigenetics of Cardiac Resilience to Stress
- Extracellular Matrix: Fibroblasts and More
- Global Roundtable: Acute Coronary Syndromes from Across the World (AHA, National Heart Foundation Hospital and Research Institute of Bangladesh, Argentine Society of Cardiology & Argentine Federation of Cardiology)
- Global Roundtable: Advances in Interventional Therapies for AS and Complex Coronary Artery Disease: AHA, Israel Heart Society, Heart and Health Foundation of Turkey, & French Society of Cardiology
- Global Roundtable: Are the Millennials (ages 15-35 years) Cardiovascular Disease Time Bombs?: AHA, Italian Association of Hospital Cardiologists, Chilean Society of Cardiology & The Danish Society of Cardiology
- Global Roundtable: Combating the Global Epidemic of Heart Failure: AHA, Gulf Heart Association, Polish Cardiac Society, Singapore Cardiac Society, & Pan African Society of Cardiology
- Global Roundtable: Comparative Effectiveness Echo-MR-Nucs 2018: AHA, European Association of Nuclear Medicine & Saudi Society of Echocardiography
- Global Roundtable: Global Efforts to Accelerate Research in Pediatric Cardiology: AHA, Mexican Society of Cardiology & Japanese Society of Pediatric Cardiology and Cardiac Surgery
- Global Roundtable: Preventing Atrial Fibrillation and Poor Outcomes: What Worldwide Data Teaches: AHA, Cardiac Society of Australia and New Zealand, Romanian Society of Cardiology & Iranian Heart Association
- Heart Failure Controversies: Perspectives from China: Joint Session with AHA & Great Wall Congress of Cardiology
- Heart Failure with Preserved Ejection Fraction: From Bench to Bedside
- His Bundle Pacing: In Sync Again
- How to Handle Device: Related Complications
- How to Manage Vasovagal Syncope and Other Cardiovascular Autonomic Disorders
- Key Issues in Global Advocacy for Rheumatic Heart Disease: Joint Session with AHA & the World Heart Federation
- Latin America at High Cardiovascular Risk: Quo Vadis in the Management of Cardiovascular Risk Control: Joint Session with AHA & the Interamerican Society of Cardiology
- Lipoprotein Metabolism and Atherosclerosis Update
- Lipoprotein(a): From Genes to Disease to Treatment
- Mechanisms of Cardiac Repair and Regeneration
- Metabolic and Oxidative Stress in Cardiovascular Disease
- Mitochondria in Cardiovascular Health and Disease I
- Mitochondria in Cardiovascular Health and Disease II
- New Concepts About Reactive Oxygen and Nitrogen Species as Signaling Molecules in the Myocardium
- New Guidelines in Arrhythmia Management: How Should These Change Patient Care?
- Novel Mechanisms of Cardiac Lineage Commitment
- Novel Small Molecule Drug Development
- Omics and Big Data in Cardiovascular Disease
- Proteostasis Meets Protein Trafficking in the Heart
- Rapid Fire Genomic and Precision Medicine
- Regulatory Mechanisms of Cardiac Growth and Remodeling
- Revascularization for Ischemic Heart Disease: The Right Time, the Right Way and the Right Place: Joint Session with AHA & the American College of Cardiology (ACC)
- Role of T-cells in Myocardial Health and Disease
- Shedding Light on the Dark Genome: Noncoding RNAS in Cardiovascular Homeostasis and Disease
- Smooth Muscle Cell Regulation in cardiovascular Disease
- Taking A Closer Look at Heart Failure in the Middle East: Joint Session with AHA & the Emirates Cardiac Society
- The Crossroads Between Cardiovascular Disease and Bioengineering
- Translational Studies in Cardiac Fibrosis
- Q & A Discussion 3 - Device Therapy and Arrhythmia Management in LVAD and Heart Transplant Recipients
- Rebuttal 1 - AF & HFrEF: The Great Debates
- Hypertension Guidelines: Consensus or Controversy?
- Sharpening The Lens On CV Symptom Management
- Big Data: Opportunities for Nurses
- Engaging Patient-Caregiver Dyads in the Management of Cardiovascular Disease
- Challenging Issues and Emerging Therapies in the Management of Sexual Dysfunction and CVD
- State of the Art Cardiovascular Care
- State of the Art Cardiovascular Care
- Young at Heart: Mechanisms Underlying Cardiac Aging - Q&A 1
- ZNA vs. DNA: How Important Is Zip Code In Care Planning? - Introduction
- ZNA vs. DNA: How Important Is Zip Code In Care Planning?
- Cognition Across the Lifespan: The Heart-Brain Connection - Introduction
- Cognition Across the Lifespan: The Heart-Brain Connection
- Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease - Q&A 1
- Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease
- Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease - Q&A 2
- Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease - Q&A 3
- Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease - Q&A 4
- Value in Healthcare: Transforming Cardiovascular Care - Mark McClellan - Moderator
- Value in Healthcare: Transforming Cardiovascular Care
- Value in Healthcare: Transforming Cardiovascular Care - Nancy Brown - Moderator
- Value in Healthcare: Transforming Cardiovascular Care - Mark McClellan - Speaker - <b><i>The Value in Healthcare Initiative: Answering the Call to Action </i></b>
- Value in Healthcare: Transforming Cardiovascular Care - Nancy Brown - Speaker - The American Heart Association Answers the Call
- Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology - Q&A 1
- Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology
- Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology - Q&A 2
- Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology - Q&A 3
- Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology - Q&A 4
- Arrhythmia Management in 2019: AHA Joint Session with Iranian Heart Association - Q&A 1
- Arrhythmia Management in 2019: AHA Joint Session with Iranian Heart Association - Q&A 2
- Arrhythmia Management in 2019: AHA Joint Session with Iranian Heart Association - Q&A 3
- Reducing the Global Burden of Cardiovascular Disease: AHA Joint Session with World Heart Federation - Q&A
- Reducing the Global Burden of Cardiovascular Disease: AHA Joint Session with World Heart Federation
- Cardiometabolic Disorders in Migrant Populations AHA Joint Session with Emirates Cardiac Society - Q&A
- Cardiometabolic Disorders in Migrant Populations AHA Joint Session with Emirates Cardiac Society
- Cardiac Remodeling Is All About Metabolism - Q&A 1
- Cardiac Remodeling Is All About Metabolism
- Cardiac Remodeling Is All About Metabolism - Q&A 3
- Cardiac Remodeling Is All About Metabolism - Q&A 4
- Cardiac Remodeling Is All About Metabolism - Q&A 5
- Trending Topics in Population Science - Q&A
- Trending Topics in Population Science
- Transatlantic Perspective on Unanswered Questions in Cardiac Critical Care: Joint AHA/ESC-ACCA - Rapid-Fire debate: Controversies in Management of Post-Cardiac Arrest Syndrome
- Transatlantic Perspective on Unanswered Questions in Cardiac Critical Care: Joint AHA/ESC-ACCA
- Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 1
- Cardiac Morphogenesis and Implications in Congenital Heart Disease
- Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 2
- Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 3
- Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 4
- Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 5
- What Are We Doing About Rare Cardiovascular Diseases?
- What Are We Doing About Rare Cardiovascular Diseases? - Q & A 2
- What Are We Doing About Rare Cardiovascular Diseases? - Q & A 3
- What Are We Doing About Rare Cardiovascular Diseases? - Q & A 5
- Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 1
- Making Spare Parts - Engineered Tissue for Cardiac Repair
- Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 2
- Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 3
- Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 4
- Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 5
- Atrial Fibrillation: How to Manage Complex Clinical Scenarios - Q & A 2
- Atrial Fibrillation: How to Manage Complex Clinical Scenarios - Q & A 3
- Atrial Fibrillation: How to Manage Complex Clinical Scenarios - Q & A 4
- Frontiers in Vascular Regeneration - Q&A 2
- Frontiers in Vascular Regeneration - Q&A 3
- Frontiers in Vascular Regeneration - Q&A 4
- Preparing for Success in Early Career - Q&A 1
- Preparing for Success in Early Career
- Publish or Perish? Rules to Live by for Early Career Authors - Session Overview
- Publish or Perish? Rules to Live by for Early Career Authors
- Publish or Perish? Rules to Live by for Early Career Authors - Kathleen A. Dracup Early Career Distinguished Award Lecture
- Mechanical Hemodynamic Support for Cardiogenic Shock in the Modern Era - Introduction
- Mechanical Hemodynamic Support for Cardiogenic Shock in the Modern Era
- Mechanical Hemodynamic Support for Cardiogenic Shock in the Modern Era - Q&A
- Why Doesn't My Patient Respond to Exercise? Gleaning Insights from Failures - Q&A 1
- Why Doesn't My Patient Respond to Exercise? Gleaning Insights from Failures
- PechaKucha Potpourri: The Key Things You Need to Know about Interesting Cardiomyopathies
- Understanding the Link Between Adiposity and Heart Failure - Q&A 1
- Managing Cardiovascular Risk in Diabetes: Ask the Experts and Challenging Cases - Q & A
- Managing Cardiovascular Risk in Diabetes: Ask the Experts and Challenging Cases
- Past Is Prologue: Recent, Ongoing and Future PAH Clinical Trials - Moderated Debate
- Past Is Prologue: Recent, Ongoing and Future PAH Clinical Trials
- Can We Prescribe a Healthy Old Age? - Audience Q&A
- Can We Prescribe a Healthy Old Age?
- Real Life Case Demonstrations - What Happens in the EP Lab Doesn't Stay in the EP Lab - Q&A 1
- Real Life Case Demonstrations - What Happens in the EP Lab Doesn't Stay in the EP Lab
- Real Life Case Demonstrations - What Happens in the EP Lab Doesn't Stay in the EP Lab - Q&A 2
- Real Life Case Demonstrations - What Happens in the EP Lab Doesn't Stay in the EP Lab - Q&A 3
- 3CPR: Shark Tank Style - Q&A 1
- 3CPR: Shark Tank Style
- 3CPR: Shark Tank Style - Q&A 2
- 3CPR: Shark Tank Style - Q&A 3
- 3CPR: Shark Tank Style - Q&A 4
- 3CPR: Shark Tank Style - Q&A 5
- New Insights into Stroke in Atrial Fibrillation - Q&A
- New Insights into Stroke in Atrial Fibrillation
- Cellular Lipids and Circulating Lipoproteins in Atherosclerosis - Q&A 1
- Cellular Lipids and Circulating Lipoproteins in Atherosclerosis
- Cellular Lipids and Circulating Lipoproteins in Atherosclerosis - Q&A 2
- Cellular Lipids and Circulating Lipoproteins in Atherosclerosis - Q&A 3
- Cellular Lipids and Circulating Lipoproteins in Atherosclerosis - Q&A 4
- AHA's Strategic Goals in 2019 and Beyond (Part 1) - Group Reports
- AHA's Strategic Goals in 2019 and Beyond (Part 1)
- Application of Epidemiologic Methods to Address Controversies in Care, Disease Burden and Policy - Q & A
- Application of Epidemiologic Methods to Address Controversies in Care, Disease Burden and Policy
- Atrial Fibrillation: Debates and Controversies
- Atrial Fibrillation: From Wearables to Guidelines - Q & A
- Atrial Fibrillation: From Wearables to Guidelines
- Cardiovascular Nursing Clinical Symposium
- Cardiovascular Nursing Clinical Symposium - Q&A 3
- Cardiovascular Nursing Clinical Symposium - Q & A 4
- Cardiovascular Nursing Clinical Symposium - Q&A 5
- Cardiovascular Nursing Clinical Symposium - Q & A 6
- Cardiovascular Nursing Clinical Symposium - Q&A 7
- Cardiovascular Nursing Clinical Symposium - Q & A 8
- Paul Dudley White International Lecture and Session - Audience Q & A
- Paul Dudley White International Lecture and Session
- Novel Concepts in Cardio-Oncology - Q&A 1
- Novel Concepts in Cardio-Oncology
- Novel Concepts in Cardio-Oncology - Q&A 2
- Novel Concepts in Cardio-Oncology - Q&A 3
- Cardio-Oncology Debates - Vote 1
- Cardio-Oncology Debates
- Cardio-Oncology Debates - Vote 2
- Cardio-Oncology Debates - Vote 3
- Current Advances in International Issues: Joint Session with AHA and Chinese Society of Cardiology - Q&A 1
- Current Advances in International Issues: Joint Session with AHA and Chinese Society of Cardiology
- Current Advances in International Issues: Joint Session with AHA and Chinese Society of Cardiology - Q&A 3
- Cardiovascular Research Using iPS Cell Technology: Joint Session with AHA and The Japanese Circulation Society - Q&A 1
- Cardiovascular Research Using iPS Cell Technology: Joint Session with AHA and The Japanese Circulation Society
- Cardiovascular Research Using iPS Cell Technology: Joint Session with AHA and The Japanese Circulation Society - Q&A 2
- Guideline Essentials - Top 5 Points from Recent Guideline/Consensus Document You Need to Know - Q&A
- Guideline Essentials - Top 5 Points from Recent Guideline/Consensus Document You Need to Know
- Make Yourself at Home: Bringing Hospital Care to the Home for Pediatric Heart Disease - Introduction
- Make Yourself at Home: Bringing Hospital Care to the Home for Pediatric Heart Disease
- ACS Management in 2019 and Beyond - Case Presentation
- ACS Management in 2019 and Beyond
- Late Breaking Science II: Results for the Ischemia Trials: To Intervene or Not to Intervene - Case Presentation
- Late Breaking Science II: Results for the Ischemia Trials: To Intervene or Not to Intervene
- Late Breaking Science II: Results for the Ischemia Trials: To Intervene or Not to Intervene - Case Revisited
- Late Breaking Science III: Controversies in Contemporary Management of AS
- Gaps in the 2018 Cholesterol Guidelines: The Great Debate(s) - Panel
- Gaps in the 2018 Cholesterol Guidelines: The Great Debate(s)
- Late Breaking Science VI: New Frontiers in Lipid Therapy - Q&A
- Late Breaking Science VI: New Frontiers in Lipid Therapy
- Addressing Essential Gaps in the Care of Patients with Atrial Fibrillation - Q&A 6
- Young at Heart: Mechanisms Underlying Cardiac Aging
- Addressing Essential Gaps in the Care of Patients with Atrial Fibrillation
- Frontiers in Vascular Regeneration
- Understanding the Link Between Adiposity and Heart Failure